We identified mutations that seem to be heterozygous and clonal as they show allele frequencies of >40 % in the WES and 46–53 % in the validation experiments (NOTCH2, SMYD1, MYD88), with the proximity to 50 % providing an indirect evidence for high tumor cell purity. Here, MYD88 is linked to neoplasm.